13D Filing: Aisling Capital II LP and Adma Biologics Inc. (ADMA)

Page 11 of 12

Page 11 of 12 – SEC Filing

CUSIP No.  000899 104
SCHEDULE 13D
Page 11 of 12

Item 7.
Material to be Filed as Exhibits.
Exhibit 1:
Joint Filing Agreement dated as of October 22, 2013, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (previously filed).
Exhibit 3:
Voting Agreement, dated as of  January 21, 2017, by and among Aisling and ADMA Biologics (previously filed).

Follow Adma Biologics Inc. (NASDAQ:ADMA)

Page 11 of 12